Chenguang Biotech Group (SHE:300138) — Market Cap & Net Worth
Market Cap & Net Worth: Chenguang Biotech Group (300138)
Chenguang Biotech Group (SHE:300138) has a market capitalization of $686.43 Million (CN¥4.69 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #10831 globally and #3021 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chenguang Biotech Group's stock price CN¥9.71 by its total outstanding shares 483100093 (483.10 Million). Review Chenguang Biotech Group (300138) total liabilities to assess the company's total debt and financial obligations.
Chenguang Biotech Group Market Cap History: 2015 to 2026
Chenguang Biotech Group's market capitalization history from 2015 to 2026. Data shows growth from $537.94 Million to $686.43 Million (5.00% CAGR).
Chenguang Biotech Group Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chenguang Biotech Group's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
Chenguang Biotech Group's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.55x
Chenguang Biotech Group's market cap is 6.55 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $537.94 Million | $1.27 Billion | $68.86 Million | 0.42x | 7.81x |
| 2016 | $553.69 Million | $2.14 Billion | $92.47 Million | 0.26x | 5.99x |
| 2017 | $541.51 Million | $2.77 Billion | $142.83 Million | 0.20x | 3.79x |
| 2018 | $347.08 Million | $3.06 Billion | $145.28 Million | 0.11x | 2.39x |
| 2019 | $506.28 Million | $3.27 Billion | $193.57 Million | 0.16x | 2.62x |
| 2020 | $1.30 Billion | $3.91 Billion | $267.74 Million | 0.33x | 4.86x |
| 2021 | $1.14 Billion | $4.87 Billion | $351.51 Million | 0.23x | 3.25x |
| 2022 | $1.22 Billion | $6.30 Billion | $434.03 Million | 0.19x | 2.82x |
| 2023 | $935.24 Million | $6.87 Billion | $479.72 Million | 0.14x | 1.95x |
| 2024 | $616.44 Million | $6.99 Billion | $94.05 Million | 0.09x | 6.55x |
Competitor Companies of 300138 by Market Capitalization
Companies near Chenguang Biotech Group in the global market cap rankings as of June 19, 2026.
Key companies related to Chenguang Biotech Group by market ranking:
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #818 globally with a market cap of $33.40 Billion USD.
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #998 globally with a market cap of $26.88 Billion USD ( CN¥183.71 Billion CNY).
- Bunge Limited (NYSE:BG): Ranked #1200 globally with a market cap of $21.79 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1591 globally with a market cap of $15.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #818 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $75.10 |
| #998 | Muyuan Foodstuff Co Ltd | SHE:002714 | $26.88 Billion | CN¥33.63 |
| #1200 | Bunge Limited | NYSE:BG | $21.79 Billion | $112.58 |
| #1591 | Tyson Foods Inc | NYSE:TSN | $15.65 Billion | $55.46 |
Chenguang Biotech Group Historical Marketcap From 2015 to 2026
Between 2015 and today, Chenguang Biotech Group's market cap moved from $537.94 Million to $ 686.43 Million, with a yearly change of 5.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥686.43 Million | -21.76% |
| 2025 | CN¥877.30 Million | +42.32% |
| 2024 | CN¥616.44 Million | -34.09% |
| 2023 | CN¥935.24 Million | -23.57% |
| 2022 | CN¥1.22 Billion | +7.03% |
| 2021 | CN¥1.14 Billion | -12.20% |
| 2020 | CN¥1.30 Billion | +157.18% |
| 2019 | CN¥506.28 Million | +45.87% |
| 2018 | CN¥347.08 Million | -35.90% |
| 2017 | CN¥541.51 Million | -2.20% |
| 2016 | CN¥553.69 Million | +2.93% |
| 2015 | CN¥537.94 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Chenguang Biotech Group was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $686.43 Million USD |
| MoneyControl | $686.43 Million USD |
| MarketWatch | $686.43 Million USD |
| marketcap.company | $686.43 Million USD |
| Reuters | $686.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chenguang Biotech Group
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more